Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$660M |
| 2 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$173M |
| 3 |
Altria Group
MO
|
+$145M |
| 4 |
Verizon
VZ
|
+$134M |
| 5 |
United Parcel Service
UPS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$181M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$148M |
| 3 |
Apple
AAPL
|
+$127M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Annexon
ANNX
$873M
| $2.59M | ﹤0.01% |
103,321
+7,738
| +8% | +$199K |
|
2527
MediaAlpha
MAX
$758M
| $2.57M | ﹤0.01% |
+65,659
| New | +$2.55M |
|
2528
Quince Therapeutics
QNCX
$26.8M
| $2.56M | ﹤0.01% |
461
+1
| +0.2% | +$8.86K |
|
|
MORF
2529
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.56M | ﹤0.01% |
76,311
+3,238
| +4% | +$95.7K |
|
2530
Peapack-Gladstone Financial
PGC
$827M
| $2.54M | ﹤0.01% |
111,501
+1,616
| +1% | +$32K |
|
|
ITOS
2531
DELISTED
iTeos Therapeutics
ITOS
| $2.53M | ﹤0.01% |
74,751
+5,610
| +8% | +$149K |
|
2532
Nurix Therapeutics
NRIX
$2.56B
| $2.53M | ﹤0.01% |
76,871
+4,662
| +6% | +$154K |
|
2533
Phathom Pharmaceuticals
PHAT
$684M
| $2.52M | ﹤0.01% |
75,898
+111
| +0.1% | +$4.5K |
|
2534
Q32 Bio
QTTB
$480M
| $2.52M | ﹤0.01% |
12,406
+97
| +0.8% | +$18.7K |
|
|
FRTA
2535
DELISTED
Forterra, Inc
FRTA
| $2.49M | ﹤0.01% |
144,701
+19,047
| +15% | +$305K |
|
2536
Midland States Bancorp
MSBI
$717M
| $2.47M | ﹤0.01% |
138,399
+2,132
| +2% | +$34.8K |
|
2537
Byline Bancorp
BY
$1.81B
| $2.47M | ﹤0.01% |
159,778
+2,339
| +1% | +$34.1K |
|
|
VIA
2538
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.45M | ﹤0.01% |
51,179
-9,761
| -16% | -$451K |
|
2539
Precision BioSciences
DTIL
$188M
| $2.44M | ﹤0.01% |
9,744
+216
| +2% | +$52.9K |
|
|
DSKE
2540
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.44M | ﹤0.01% |
419,187
+9,741
| +2% | +$62.1K |
|
|
JOBS
2541
DELISTED
51job Inc
JOBS
| $2.44M | ﹤0.01% |
34,781
+1,044
| +3% | +$75.4K |
|
|
RFP
2542
DELISTED
Resolute Forest Products Inc.
RFP
| $2.41M | ﹤0.01% |
368,772
-14,410
| -4% | -$78.4K |
|
|
GDEN
2543
DELISTED
Golden Entertainment
GDEN
| $2.4M | ﹤0.01% |
120,845
+2,017
| +2% | +$32.4K |
|
2544
Motorcar Parts of America
MPAA
$258M
| $2.4M | ﹤0.01% |
122,179
-33
| -0% | -$613 |
|
2545
Oportun Financial
OPRT
$276M
| $2.39M | ﹤0.01% |
123,294
+6,895
| +6% | +$113K |
|
2546
Icon
ICLR
$12.1B
| $2.39M | ﹤0.01% |
12,233
+45
| +0.4% | +$8.8K |
|
|
ODT
2547
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $2.39M | ﹤0.01% |
124,270
+36,614
| +42% | +$565K |
|
|
CIVI
2548
DELISTED
Civitas Resources
CIVI
| $2.35M | ﹤0.01% |
121,430
-313
| -0.3% | -$6.58K |
|
|
GBIO
2549
DELISTED
Generation Bio
GBIO
| $2.34M | ﹤0.01% |
8,260
+183
| +2% | +$58.7K |
|
2550
CytomX Therapeutics
CTMX
$723M
| $2.32M | ﹤0.01% |
354,643
+31,401
| +10% | +$224K |
|
Similar funds
Charles Schwab's Q4 2020 Portfolio in Review
As of Q4 2020, Charles Schwab held 3,457 positions worth $252B, up 16% from $217B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q4 2020 filing shows 113 new, 2,243 increased, 711 reduced and 62 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M. The largest sale was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2020 buy was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M.
- Charles Schwab added most to Tesla in Q4 2020, an estimated $660M increase.
- Charles Schwab's biggest Q4 2020 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $181M.
- Charles Schwab fully exited iShares MSCI Germany ETF in Q4 2020, selling an estimated $148M.
- Charles Schwab's ten largest holdings make up 17% of its $252B portfolio in Q4 2020.
- Charles Schwab opened 113 new positions and closed 62 in Q4 2020.
- Charles Schwab's portfolio value rose 16% quarter-over-quarter to $252B.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.